AAAAAA
Results: 1-25/31
Authors:
Demeure, CE
Wolfers, J
Martin-Garcia, N
Gaulard, P
Triebel, F
Citation: Ce. Demeure et al., T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts, EUR J CANC, 37(13), 2001, pp. 1709-1718
Authors:
Agrawal, SG
Marquet, J
Plumas, J
Rouard, H
Delfau-Larue, MH
Gaulard, P
Boumsell, L
Reyes, F
Bensussan, A
Farcet, JP
Citation: Sg. Agrawal et al., Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue, INT IMMUNOL, 13(4), 2001, pp. 441-450
Authors:
Allory, Y
Challine, D
Haioun, C
Copie-Bergman, C
Delfau-Larue, MH
Boucher, E
Charlotte, F
Fabre, M
Michel, M
Gaulard, P
Citation: Y. Allory et al., Bone marrow involvement in lymphomas with hemophagocytic syndrome at presentation - A clinicopathologic study of 11 patients in a western institution, AM J SURG P, 25(7), 2001, pp. 865-874
Authors:
Cazals-Hatem, D
Andre, M
Mounier, N
Copin, MC
Divine, M
Berger, F
Bosly, A
Kerneis, Y
Briere, J
Quesnel, B
Diebold, J
Gaulard, P
Citation: D. Cazals-hatem et al., Pathologic and clinical features of 77 Hodgkin's lymphoma patients treatedin a lymphoma protocol (LNH87) - A GELA study, AM J SURG P, 25(3), 2001, pp. 297-306
Authors:
Petit, B
Leroy, K
Kanavaros, P
Boulland, ML
Druet-Cabanac, M
Haioun, C
Bordessoule, D
Gaulard, P
Citation: B. Petit et al., Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations, HUMAN PATH, 32(2), 2001, pp. 196-204
Authors:
Rahmouni, A
Divine, M
Lepage, E
Jazaerli, N
Belhadj, K
Gaulard, P
Golli, M
Reyes, F
Vasile, N
Citation: A. Rahmouni et al., Mediastinal lymphoma: Quantitative changes in gadolinium enhancement at MRimaging after treatment, RADIOLOGY, 219(3), 2001, pp. 621-628
Authors:
Brauninger, A
Spieker, T
Willenbrock, K
Gaulard, P
Wacker, HH
Rajewsky, K
Hansmann, ML
Kuppers, R
Citation: A. Brauninger et al., Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) Epstein-Barr virus-infected B cells in angioimmunoblastic Tcell lymphoma, J EXP MED, 194(7), 2001, pp. 927-940
Authors:
Tordjman, R
Delaire, S
Plouet, J
Ting, S
Gaulard, P
Fichelson, S
Romeo, PH
Lemarchandel, V
Citation: R. Tordjman et al., Erythroblasts are a source of angiogenic factors, BLOOD, 97(7), 2001, pp. 1968-1974
Authors:
Camilleri-Broet, S
Audouin, J
Ferme, C
Briere, J
Pulford, K
Gaulard, P
Divine, M
Macintyre, E
Delsol, G
Berger, F
Citation: S. Camilleri-broet et al., ALK is not expressed in Hodgkin disease, BLOOD, 97(6), 2001, pp. 1901-1902
Authors:
Lechapt-Zalcman, E
Challine, D
Delfau-Larue, MH
Haioun, C
Desvaux, D
Gaulard, P
Citation: E. Lechapt-zalcman et al., Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man, ARCH PATH L, 125(9), 2001, pp. 1246-1248
Authors:
Kanavaros, P
Boulland, ML
Petit, B
Arnulf, B
Gaulard, P
Citation: P. Kanavaros et al., Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: Association with extranodal site, NK or T gamma delta phenotype, anaplastic morphology and CD30 expression, LEUK LYMPH, 38(3-4), 2000, pp. 317-326
Authors:
Stamatoullas, A
Buchonnet, G
Lepretre, S
Lenain, P
Lenormand, S
Duval, C
Callat, MP
Gaulard, P
Bastard, C
Tilly, H
Citation: A. Stamatoullas et al., De novo acute B cell leukemia/lymphoma with t(14;18), LEUKEMIA, 14(11), 2000, pp. 1960-1966
Authors:
Haioun, C
Lepage, E
Gisselbrecht, C
Salles, G
Coiffier, B
Brice, P
Bosly, A
Morel, P
Nouvel, C
Tilly, H
Lederlin, P
Sebban, C
Briere, J
Gaulard, P
Reyes, F
Citation: C. Haioun et al., Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study, J CL ONCOL, 18(16), 2000, pp. 3025-3030
Authors:
Charton-Bain, MC
Brousset, P
Bouabdallah, R
Gaulard, P
Merlio, JP
Dubus, P
Rostaing, L
de Roux, C
Weiller, PJ
Hassoun, J
Xerri, L
Citation: Mc. Charton-bain et al., Variation in the histological pattern of nodal involvement by gamma/delta T-cell lymphoma, HISTOPATHOL, 36(3), 2000, pp. 233-239
Authors:
Boulland, ML
Wechsler, J
Bagot, M
Pulford, K
Kanavaros, P
Gaulard, P
Citation: Ml. Boulland et al., Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins, HISTOPATHOL, 36(2), 2000, pp. 136-144
Authors:
Meignin, V
Briere, J
Brice, P
Gisselbrecht, C
Gaulard, P
Janin, A
Citation: V. Meignin et al., Lymphocytic predominant Hodgkin's disease or type I Hodgkin's disease (paragranuloma of Poppema-Lennert): a clinicopathological entity. Study of 21 cases and review of the literature, ANN PATHOL, 20(1), 2000, pp. 19-24
Authors:
Zompi, S
Tulliez, M
Conti, F
Leblond, V
Gaulard, P
Blanche, P
Durand, F
Ghandi, D
Dreyfus, F
Louvel, A
Calmus, Y
Bouscary, D
Citation: S. Zompi et al., Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases, J HEPATOL, 32(3), 2000, pp. 521-527
Authors:
Suarez, F
Wlodarska, I
Rigal-Huguet, F
Mempel, M
Martin-Garcia, N
Farcet, JP
Delsol, G
Gaulard, P
Citation: F. Suarez et al., Hepatosplenic alpha beta T-cell lymphoma - An unusual case with clinical, histologic, and cytogenetic features of gamma delta hepatosplenic T-cell lymphoma, AM J SURG P, 24(7), 2000, pp. 1027-1032
Authors:
Blakolmer, K
Gaulard, P
Mannhalter, C
Swerdlow, S
Fassati, LR
Rossi, G
Maggi, U
Conte, D
Demetris, AJ
Citation: K. Blakolmer et al., Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft, TRANSPLANT, 70(12), 2000, pp. 1802-1805
Authors:
Dierlamm, J
Baens, M
Stefanova-Ouzounova, M
Hinz, K
Wlodarska, I
Maes, B
Steyls, A
Driessen, A
Verhoef, G
Gaulard, P
Hagemeijer, A
Hossfeld, DK
De Wof-Peeters, C
Marynen, P
Citation: J. Dierlamm et al., Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes, BLOOD, 96(6), 2000, pp. 2215-2218
Authors:
Adida, C
Haioun, C
Gaulard, P
Lepage, E
Morel, P
Briere, J
Dombret, H
Reyes, F
Diebold, J
Gisselbrecht, C
Salles, G
Altieri, DC
Molina, TJ
Citation: C. Adida et al., Prognostic significance of survivin expression in diffuse large B-cell lymphomas, BLOOD, 96(5), 2000, pp. 1921-1925
Authors:
Hezode, C
Duvoux, C
Germanidis, G
Roudot-Thoraval, F
Vincens, AL
Gaulard, P
Cherqui, D
Pawlotsky, JM
Dhumeaux, D
Citation: C. Hezode et al., Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation, HEPATOLOGY, 30(3), 1999, pp. 775-778
Authors:
Kanavaros, P
Vlychou, M
Stefanaki, K
Rontogianni, D
Gaulard, P
Pantelidaki, E
Zois, M
Darivianaki, K
Georgoulias, V
Boulland, ML
Gorgoulis, V
Kittas, C
Citation: P. Kanavaros et al., Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease, ANTICANC R, 19(2A), 1999, pp. 1209-1216
Authors:
Bouron, D
Leger-Ravet, MB
Gaulard, P
Franco, D
Capron, F
Citation: D. Bouron et al., Unusual hepatic neoplasm - B-cell lymphoma (of the polymorphous centroblastic type according to the Kiel classification) developed on a low-grade primary hepatic lymphoma of the malt variety, ANN PATHOL, 19(6), 1999, pp. 547-548
Authors:
Conti, F
Calmus, Y
Rouer, E
Gaulard, P
Louvel, A
Houssin, D
Zafrani, ES
Citation: F. Conti et al., Increased expression of interleukin-4 during liver allograft rejection, J HEPATOL, 30(5), 1999, pp. 935-943